SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
February 12, 1997
Mallinckrodt Inc.
(Exact name of registrant as specified in its charter)
New York 1-483 36-1263901
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
7733 Forsyth Boulevard, St. Louis, MO 63105-1820
(Address of principal executive offices) (ZIP Code)
Registrant's telephone number, (314) 854-5200
including area code
<PAGE>
Item 5. Other Events
A press release was issued February 12, 1997. The relevant portion
of the text of that release was as follows:
MALLINCKRODT TO SUPPLY RADIOPHARMACEUTICALS
TO PREMIER, INC.'S, 1,800 HOSPITAL AND HEALTHCARE ORGANIZATIONS
ST. LOUIS, Mo., February 12, 1997 -- Mallinckrodt Inc. (NYSE:MKG)
announced today that it has entered into an exclusive agreement to
supply radiopharmaceuticals and associated products to the 1,800
owner hospitals and affiliates of Premier, Inc., the largest
healthcare alliance in the United States. The five-year agreement,
effective April 1, covers a full range of products and accessories
used in nuclear medicine imaging procedures.
A Premier task group cited Mallinckrodt's fully integrated
manufacturing and distribution systems and its broad portfolio of
products as reasons for selecting Mallinckrodt as the sole nuclear
medicine supplier. Premier members will receive improved value and
universal access to imaging and therapeutic radiopharmaceutical
products, the task force said.
This agreement places two of Mallinckrodt's key healthcare
product lines under contract with Premier. Mallinckrodt already
supplies Premier members with a variety of contrast media for use
with X-ray and other imaging technologies.
"This contract award represents our expanded commitment to all
Premier members to deliver quality products and services that reduce
the cost of delivering healthcare," said C. Ray Holman, chairman and
chief executive officer of Mallinckrodt. "We are committed to a
long-term partnership with Premier that will transcend the customary
vendor-buyer relationship."
Mallinckrodt is an international growth company serving
specialty markets in human healthcare and chemicals. Dedicated to
improving healthcare and chemistry, the company is a major producer
of diagnostic imaging agents, medical devices, analgesic
pharmaceuticals, catalysts, and laboratory and microelectronic
chemicals. The St. Louis, Missouri-based company, with fiscal 1996
net sales of $2.2 billion, sells more than 2,000 products in more
than 100 countries. Mallinckrodt employs about 10,400 people
worldwide. The Mallinckrodt web site address is
(www.mallinckrodt.com).
Premier, Inc., resulted in early 1996 from the merger of the
former American Healthcare Systems, Inc. (AmHS), based in San Diego,
Calif.; SunHealth Alliance, Inc., based in Charlotte, N. C.; and
Premier Health Alliance, Inc., based in Chicago, Ill. The new
Premier continues to maintain major offices in these locations and in
Washington, D. C., to serve its 250 owners, the 700 hospitals and
healthcare facilities they operate, and approximately 1,100 other
affiliated hospital and healthcare organizations. Group purchasing
of supplies, pharmaceuticals and equipment through Premier Purchasing
Partners, L. P., is one of the major programs Premier operates to
support its owners' and affiliates' efforts to hold down healthcare
costs, improve quality and stay ahead of advances in clinical
knowledge, technology and market changes such as managed care.
Premier also operates substantial units that provide insurance,
clinical equipment services and technology assessment services,
benchmarking and re-engineering support, comparative databases and
other decision-support services, and extensive consulting and on-site
support in areas from process and performance improvement to managed
care and marketing and information technology management.
# # #
Mallinckrodt, Inc.
ROGER A. KELLER
Vice President, Secretary
and General Counsel
DATE: February 12, 1997
